Patent Yard Sign in
European application, no grantEurope

Medicament for the treatment or improvement of rheumatoid arthritis or systemic lupus erythematosus

EP 0262802 A2 · Applicant: Takeda Chemical Industries, Ltd.

EPO PDF

Overview

The published document from the EPO: abstract, claims, description and drawings. Open it full size

Read the whole patent

Listed from its EPO record in Patent Yard's archive of European patents past their term. Its claims, description and drawings are in the EPO PDF and on Google Patents, and the Claude kit works from them.

Google PatentsEPO PDF

Why it's free to use

  • Filed August 28, 1987 and never granted as a European patent. Had it been granted, its 20-year term would have ended August 28, 2007.
  • A supplementary protection certificate, which can extend a medicine or crop-protection patent, adds at most five and a half years, so even that would have ended by February 28, 2013.
  • We check European rights only. A US or other national patent in its family could still be in force: check its family on Espacenet or Google Patents.
FiledAugust 28, 1987
PublishedApril 6, 1988
GrantedNever granted
Term endedAugust 28, 2007
Application numberEP 87307671
Classification (CPC)A61K38/2013

Timeline

Timeline From EPO dates

1988199019921994199619982000200220042006Application filedAug 28, 1987PublishedApril 6, 1988Term endedAug 28, 2007

Sources & verification

Official EPO records

Full published documentClaims, description and drawings as a PDF.EPOEuropean Patent RegisterProcedure, status, file inspection and legal events.EPOLinked open EP data recordThe bibliographic record this page is built from.EPO

Cross-check elsewhere

Google PatentsFull text, worldwide family, citing patents and legal events.patents.google.comEspacenetNational family members and their legal status.European Patent Office

Everything on this page comes from the EPO record linked above. EPO data used under CC BY 4.0.